Excelsior Biopharma Inc. (TPEX:6496)
Taiwan
· Delayed Price · Currency is TWD 26.20
-0.85 (-3.14%)
At close: Mar 9, 2026
Excelsior Biopharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,225 | 1,367 | 1,406 | 1,356 | 1,298 | 1,363 | Upgrade
|
| Market Cap Growth | -16.54% | -2.78% | 3.69% | 4.50% | -4.79% | -1.48% | Upgrade
|
| Enterprise Value | 1,551 | 1,666 | 1,504 | 756 | 549 | 605 | Upgrade
|
| Last Close Price | 26.20 | 29.25 | 29.95 | 28.85 | 27.80 | 29.25 | Upgrade
|
| PS Ratio | 1.36 | 1.52 | 1.63 | 1.76 | 1.93 | 1.02 | Upgrade
|
| PB Ratio | 1.52 | 1.70 | 1.42 | 1.23 | 1.08 | 1.11 | Upgrade
|
| P/TBV Ratio | 1.52 | 1.70 | 1.42 | 1.23 | 1.08 | 1.11 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 25.75 | Upgrade
|
| P/OCF Ratio | - | - | - | - | 236.59 | 24.42 | Upgrade
|
| EV/Sales Ratio | 1.73 | 1.86 | 1.75 | 0.98 | 0.82 | 0.45 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 94.72 | Upgrade
|
| EV/FCF Ratio | -8.83 | - | - | - | - | 11.43 | Upgrade
|
| Debt / Equity Ratio | 0.64 | 0.64 | 0.41 | 0.32 | 0.29 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 18.34 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 6.89 | Upgrade
|
| Net Debt / Equity Ratio | 0.41 | 0.41 | 0.16 | -0.21 | -0.62 | -0.60 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.26 | -3.26 | -2.42 | 3.40 | 46.03 | -115.59 | Upgrade
|
| Net Debt / FCF Ratio | -1.86 | -1.86 | -0.45 | 1.38 | 328.79 | -13.94 | Upgrade
|
| Asset Turnover | 0.59 | 0.59 | 0.55 | 0.47 | 0.38 | 0.72 | Upgrade
|
| Inventory Turnover | 1.83 | 1.83 | 1.85 | 2.29 | 1.96 | 4.35 | Upgrade
|
| Quick Ratio | 1.13 | 1.13 | 1.95 | 4.53 | 2.71 | 5.26 | Upgrade
|
| Current Ratio | 1.95 | 1.95 | 3.43 | 5.92 | 3.15 | 6.12 | Upgrade
|
| Return on Equity (ROE) | -20.40% | -20.40% | -9.42% | -7.87% | -2.77% | -1.24% | Upgrade
|
| Return on Assets (ROA) | -7.00% | -7.00% | -3.21% | -3.08% | -1.03% | -0.29% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.08% | -15.05% | -8.02% | -12.28% | -6.20% | -1.76% | Upgrade
|
| Return on Capital Employed (ROCE) | -15.40% | -15.40% | -6.00% | -5.70% | -2.30% | -0.60% | Upgrade
|
| Earnings Yield | -14.96% | -13.40% | -7.02% | -6.71% | -2.60% | -1.15% | Upgrade
|
| FCF Yield | -14.34% | -12.85% | -25.38% | -12.56% | -0.18% | 3.88% | Upgrade
|
| Buyback Yield / Dilution | -0.07% | -0.07% | -0.42% | -0.15% | 1.42% | 5.56% | Upgrade
|
| Total Shareholder Return | -0.07% | -0.07% | -0.42% | -0.15% | 1.42% | 5.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.